Exploiting the defensive sugars of HIV-1 for drug and vaccine design
The sustained effort towards developing an antibody vaccine against HIV/AIDS has provided much of our understanding of viral immunology. It is generally accepted that one of the main barriers to antibody neutralization of HIV is the array of protective structural carbohydrates that covers the antige...
Main Authors: | Scanlan, C, Offer, J, Zitzmann, N, Dwek, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Nature Research
2007
|
Similar Items
-
Emerging principles for the therapeutic exploitation of glycosylation.
by: Dalziel, M, et al.
Published: (2014) -
Sugar immunogens
by: Dwek, R, et al.
Published: (2009) -
Antigenic mimicry of the HIV envelope by AIDS-Associated pathogens
by: Dunlop, D, et al.
Published: (2008) -
Antigenic mimicry of the HIV envelope by AIDS-associated pathogens.
by: Dunlop, D, et al.
Published: (2008) -
Yeast mannan genetics controls the molecular specificity of anti-carbohydrate antibodies cross-reactive to the HIV envelope
by: Dunlop, D, et al.
Published: (2009)